| P50 | author | David Henshall | Q42680688 |
| P2093 | author name string | Cristina R Reschke | |
| P2860 | cites work | De novo mutations in epileptic encephalopathies | Q24621776 |
| | Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood-brain barrier permeability | Q24642922 |
| | An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP | Q24645518 |
| | miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex | Q24653722 |
| | Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 |
| | NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses | Q24670080 |
| | Diverse mechanisms of antiepileptic drugs in the development pipeline | Q24675330 |
| | Cyclooxygenase-2 in epilepsy. | Q26827095 |
| | Development, maintenance and disruption of the blood-brain barrier | Q26829668 |
| | MicroRNAs in the pathophysiology and treatment of status epilepticus | Q27004814 |
| | ILAE official report: a practical clinical definition of epilepsy | Q27009103 |
| | Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist | Q27022395 |
| | The Crystal Structure of Human Argonaute2 | Q27678770 |
| | Oncomirs - microRNAs with a role in cancer | Q27860773 |
| | Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain | Q37013773 |
| | The emerging roles of microRNAs in CNS injuries | Q37128646 |
| | High-dose rapamycin blocks mossy fiber sprouting but not seizures in a mouse model of temporal lobe epilepsy | Q37161103 |
| | The challenge and promise of anti-epileptic therapy development in animal models | Q37214420 |
| | Epidemiology and classification of epilepsy: gender comparisons | Q37301512 |
| | Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus | Q37352375 |
| | Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications | Q37553909 |
| | MicroRNAs as biomarkers for CNS cancer and other disorders | Q37728119 |
| | Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature | Q37803281 |
| | The role of inflammation in epilepsy | Q37816957 |
| | Circulating microRNAs: Association with disease and potential use as biomarkers | Q37818867 |
| | Mechanisms of epileptogenesis and potential treatment targets | Q37831588 |
| | microRNAs in neurons: manifold regulatory roles at the synapse | Q37874365 |
| | Epilepsy and brain inflammation | Q37943908 |
| | Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? | Q37981140 |
| | Long-term epilepsy-associated tumors | Q38002123 |
| | Epilepsy and microRNA. | Q38088897 |
| | Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases | Q38103194 |
| | MicroRNA regulation and dysregulation in epilepsy | Q38151088 |
| | MicroRNA-132, -134, and -138: a microRNA troika rules in neuronal dendrites | Q38227729 |
| | Potassium channel genes and benign familial neonatal epilepsy | Q38246525 |
| | Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis | Q35962195 |
| | Defining "epileptogenesis" and identifying "antiepileptogenic targets" in animal models of acquired temporal lobe epilepsy is not as simple as it might seem | Q36098745 |
| | Estimation of the burden of active and life-time epilepsy: a meta-analytic approach | Q36135562 |
| | Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response | Q36192088 |
| | Cell-free Circulating miRNA Biomarkers in Cancer | Q36316601 |
| | Brain inflammation in epilepsy: experimental and clinical evidence | Q36319367 |
| | Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death. | Q36361562 |
| | Deletion of astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degeneration | Q36405113 |
| | General principals of miRNA biogenesis and regulation in the brain. | Q36465866 |
| | Epigenetics and epilepsy. | Q36493159 |
| | Cortical Tubers: Windows into Dysregulation of Epilepsy Risk and Synaptic Signaling Genes by MicroRNAs | Q36533812 |
| | Genetic neurological channelopathies | Q36577288 |
| | Loss of microRNAs in pyramidal neurons leads to specific changes in inhibitory synaptic transmission in the prefrontal cortex | Q36733299 |
| | Gene expression profile in temporal lobe epilepsy | Q36778564 |
| | Development of new antiepileptic drugs: challenges, incentives, and recent advances | Q36913503 |
| | Widespread changes in protein synthesis induced by microRNAs | Q27860886 |
| | Identification of tissue-specific microRNAs from mouse | Q27860892 |
| | Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 |
| | TDP2 protects transcription from abortive topoisomerase activity and is required for normal neural function | Q28118952 |
| | Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 |
| | A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology | Q28203348 |
| | Current prospects for RNA interference-based therapies | Q28235733 |
| | Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) | Q28243974 |
| | Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy | Q28273764 |
| | Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy | Q28281986 |
| | MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells | Q28287986 |
| | RNA and microRNAs in fragile X mental retardation | Q28290772 |
| | Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats | Q28307917 |
| | Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132 | Q28510360 |
| | Unique behavioral characteristics and microRNA signatures in a drug resistant epilepsy model | Q28538727 |
| | Treatment of HCV infection by targeting microRNA | Q29547712 |
| | A brain-specific microRNA regulates dendritic spine development | Q29614753 |
| | A microRNA array reveals extensive regulation of microRNAs during brain development | Q29618667 |
| | Microglia: a sensor for pathological events in the CNS | Q29620556 |
| | The relevance of kindling for human epilepsy | Q30443860 |
| | A role for leukocyte-endothelial adhesion mechanisms in epilepsy | Q30488791 |
| | Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects | Q30524857 |
| | Transcranial amelioration of inflammation and cell death after brain injury. | Q30572360 |
| | Genome-wide microRNA expression profiles in hippocampus of rats with chronic temporal lobe epilepsy | Q30576606 |
| | miR-21 improves the neurological outcome after traumatic brain injury in rats | Q30596128 |
| | Different microRNA profiles in chronic epilepsy versus acute seizure mouse models | Q30617784 |
| | Sex differences in human epilepsy | Q30804430 |
| | Electroshocks delay seizures and subsequent epileptogenesis but do not prevent neuronal damage in the lithium-pilocarpine model of epilepsy | Q31440423 |
| | The differential diagnosis of epilepsy: a critical review | Q33157134 |
| | Whole transcriptome analysis of the hippocampus: toward a molecular portrait of epileptogenesis | Q33551031 |
| | Cellular injury and neuroinflammation in children with chronic intractable epilepsy | Q33611760 |
| | Different timings of Dicer deletion affect neurogenesis and gliogenesis in the developing mouse central nervous system | Q33701894 |
| | Drug resistance in brain diseases and the role of drug efflux transporters. | Q33988704 |
| | Seizure-promoting effect of blood-brain barrier disruption | Q34056074 |
| | Expression profile of microRNAs in rat hippocampus following lithium-pilocarpine-induced status epilepticus. | Q54396512 |
| | Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. | Q54408211 |
| | Circulating microRNAs in patients with coronary artery disease. | Q54421687 |
| | Epilepsy | Q55899118 |
| | The first case of myoclonic epilepsy in a child with a de novo 22q11.2 microduplication | Q58833704 |
| | Chronic seizures and collateral sprouting of dentate mossy fibers after kainic acid treatment in rats | Q68011756 |
| | Mossy fiber synaptic reorganization in the epileptic human temporal lobe | Q69240649 |
| | Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid | Q71269861 |
| | Classification of epileptic disorders | Q74151108 |
| | Secondary Epileptogenic Lesions | Q78841427 |
| | Caspase-3 cleavage and nuclear localization of caspase-activated DNase in human temporal lobe epilepsy | Q81112622 |
| | Drosha regulates neurogenesis by controlling neurogenin 2 expression independent of microRNAs | Q84393849 |
| | Animal models | Q84911677 |
| | Identification of miRNAs differentially expressed in human epilepsy with or without granule cell pathology | Q34078569 |
| | Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs | Q34162438 |
| | Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b | Q34168627 |
| | Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. | Q34170732 |
| | Standards for epidemiologic studies and surveillance of epilepsy | Q34214261 |
| | A permanent change in brain function resulting from daily electrical stimulation | Q34225550 |
| | The kindling model of epilepsy: a review | Q34246193 |
| | The hidden genetics of epilepsy-a clinically important new paradigm | Q34415194 |
| | MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. | Q34418730 |
| | MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response | Q34427432 |
| | Neurocritical care: status epilepticus review. | Q34440543 |
| | The impact of microglial activation on blood-brain barrier in brain diseases. | Q34442604 |
| | Localization of cholinergic muscarinic receptors in rat brain by light microscopic radioautography | Q34448324 |
| | Prevention or Modification of Epileptogenesis after Brain Insults: Experimental Approaches and Translational Research | Q34458158 |
| | Changes in microRNA expression in the whole hippocampus and hippocampal synaptoneurosome fraction following pilocarpine induced status epilepticus | Q34545095 |
| | The blood-brain barrier and epilepsy | Q34583073 |
| | TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis | Q34583749 |
| | Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy | Q34584249 |
| | Review: Hippocampal sclerosis in epilepsy: a neuropathology review | Q34692930 |
| | Adding fuel to fire: microRNAs as a new class of mediators of inflammation. | Q34885280 |
| | RNAi medicine for the brain: progresses and challenges. | Q34982838 |
| | Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures | Q34992471 |
| | Alterations in miRNA levels in the dentate gyrus in epileptic rats. | Q35022607 |
| | Genome-wide microRNA profiling of rat hippocampus after status epilepticus induced by amygdala stimulation identifies modulators of neuronal apoptosis | Q35036382 |
| | miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia | Q35105106 |
| | A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA sequencing | Q35157739 |
| | Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy | Q35172480 |
| | Identification of endogenous reference genes for the analysis of microRNA expression in the hippocampus of the pilocarpine-induced model of mesial temporal lobe epilepsy | Q35194710 |
| | miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132 | Q35475193 |
| | Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy. | Q35533933 |
| | Candidate drug targets for prevention or modification of epilepsy | Q35594944 |
| | Expression profiling of synaptic microRNAs from the adult rat brain identifies regional differences and seizure-induced dynamic modulation | Q35606143 |
| | Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11.2 deletion syndrome | Q35695641 |
| | Therapeutic devices for epilepsy | Q35813170 |
| | Neurotrophin-3 mRNA a putative target of miR21 following status epilepticus | Q38330929 |
| | Epilepsy: new advances | Q39122505 |
| | miRNA expression analysis in cortical dysplasia: regulation of mTOR and LIS1 pathway | Q39246470 |
| | Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma | Q39638219 |
| | Caspase-dependent conversion of Dicer ribonuclease into a death-promoting deoxyribonuclease. | Q39753665 |
| | Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy | Q39893640 |
| | How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit | Q40287487 |
| | Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis? | Q40705824 |
| | The functional relationship between antidromically evoked field responses of the dentate gyrus and mossy fiber reorganization in temporal lobe epileptic patients | Q41126675 |
| | Expression levels of microRNA-199 and hypoxia-inducible factor-1 alpha in brain tissue of patients with intractable epilepsy | Q41651826 |
| | MicroRNA-128 governs neuronal excitability and motor behavior in mice | Q41833350 |
| | MiR-134 blockade prevents status epilepticus like-activity and is neuroprotective in cultured hippocampal neurons | Q42219802 |
| | MicroRNA-34a upregulation during seizure-induced neuronal death | Q42560262 |
| | Loss of p53 results in protracted electrographic seizures and development of an aggravated epileptic phenotype following status epilepticus | Q42575321 |
| | Aberrant expression of miR-218 and miR-204 in human mesial temporal lobe epilepsy and hippocampal sclerosis-convergence on axonal guidance | Q42775825 |
| | Association of the severity of cortical damage with the occurrence of spontaneous seizures and hyperexcitability in an animal model of posttraumatic epilepsy | Q43077187 |
| | Mef2-mediated transcription of the miR379-410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels | Q43079834 |
| | Homeostatic control of brain function - new approaches to understand epileptogenesis. | Q43090447 |
| | Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures | Q43116251 |
| | Delayed sclerosis, neuroprotection, and limbic epileptogenesis after status epilepticus in the rat. | Q44066396 |
| | CHOP regulates the p53-MDM2 axis and is required for neuronal survival after seizures | Q44156574 |
| | The ontogeny of excitatory amino acid receptors in the rat forebrain--II. Kainic acid receptors | Q44169950 |
| | Antagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in vivo and protect against pilocarpine-induced status epilepticus | Q44393750 |
| | Hippocampal subregion-specific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy | Q44430535 |
| | Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. | Q44487940 |
| | Microinjection of kainic acid into the rat hippocampus | Q44606762 |
| | Expressions of tumor necrosis factor alpha and microRNA-155 in immature rat model of status epilepticus and children with mesial temporal lobe epilepsy | Q45180901 |
| | Effects of status epilepticus early in life on susceptibility to ischemic injury in adulthood | Q46427190 |
| | Cyclooxygenase-2/PGE2 pathway facilitates pentylenetetrazol-induced seizures. | Q46768006 |
| | Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy | Q46954553 |
| | miR-92a regulates expression of synaptic GluA1-containing AMPA receptors during homeostatic scaling. | Q47993213 |
| | The effects of sleep deprivation on microRNA expression in rats submitted to pilocarpine-induced status epilepticus | Q48125538 |
| | Expression patterns of miR-124, miR-134, miR-132, and miR-21 in an immature rat model and children with mesial temporal lobe epilepsy | Q48212966 |
| | Microglial and astroglial reactions to ischemic and kainic acid-induced lesions of the adult rat hippocampus | Q48329229 |
| | Interleukin-1β and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy | Q48469394 |
| | Rapamycin reveals an mTOR-independent repression of Kv1.1 expression during epileptogenesis | Q48503841 |
| | Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures | Q48526585 |
| | Mossy fiber synaptic reorganization induced by kindling: time course of development, progression, and permanence. | Q48661605 |
| | Epidemiology: The complexities of epilepsy | Q48662000 |
| | Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events | Q48701161 |
| | Long-term effects of intrahippocampal kainic acid injection in rats: a method for inducing spontaneous recurrent seizures | Q48942375 |
| | Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death | Q49116308 |
| | Effects on EEG of the osmotic opening of the blood-brain barrier in rats. | Q50943103 |
| | Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. | Q51052283 |
| | One Argonaute family member, Eif2c2 (Ago2), is essential for development and appears not to be involved in DNA methylation. | Q51989532 |
| | Gender differences in epilepsy. | Q53272136 |
| | ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. | Q53623056 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 41-70 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Advances in Experimental Medicine and Biology | Q4686385 |
| P1476 | title | microRNA and Epilepsy | |
| P478 | volume | 888 | |